findmyKOL
Clinical trialNCT03968406RecruitingPhase 1Interventional

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

SponsorM.D. Anderson Cancer CenterEnrollment24Malignant Female Reproductive System NeoplasmRecurrent Cervical CarcinomaRecurrent Endometrial CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma+19 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Johns Hopkins University/sidney Kimmel Cancer Center

    Baltimore, Maryland, United States

    Stéphanie Gaillard, MD PhD
    Recruiting
  • M D Anderson Cancer Center

    Houston, Texas, United States

    Lilie L. Lin
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Sept 2019
Primary completion
1 Oct 2027
Completion
1 Oct 2027
Last update posted
11 Mar 2026
Registered enrollment
24
Registry id
NCT03968406

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.